The Union World Conference on Lung Health 2024 in Bali, hosted by The Union, gathered over 4,000 delegates globally to discuss cutting-edge research and initiatives focused on lung health.
Scaling up advanced TB diagnostic technologies
At this prestigious academic event, Zeesan showcased its comprehensive products to the global audience, encompassing a broad spectrum of diagnostic solutions including tuberculosis detection, NTM identification, drug susceptibility testing, personalized medication guidance, and rapid genotyping and tracing. Notably, Zeesan’s Sanity 2.0 System stood out for its revolutionary contribution to tuberculosis diagnostics, offering an intuitive user interface and robust multi-disease detection capabilities.
Delivering Comprehensive Molecular Drug Resistance Solutions for Tuberculosis
Prof. Li Qingge, the professor of Xiamen University and the founder of Zeesan, delivered a keynote at Union WCLH 2024, highlighting the Zeesan’s innovative tuberculosis molecular diagnostics. These solutions enhance testing accuracy, reliability, and ease-of-use, offering comprehensive resistance tests for both first and second-line TB drugs. Zeesan’s innovative kits address global diagnostic needs and contribute to the worldwide effort to combat tuberculosis.
Engaging in deep discussions with global experts, Zeesan has further showcased the versatility of its tuberculosis molecular diagnostics in diverse diagnostic settings. Zeesan will foster collaborations across borders and disciplines, which will undoubtedly drive advancements in TB diagnostic technology and intensify the global efforts to eradicate tuberculosis.
Dec 20,2024